The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry disease

被引:0
|
作者
Solrun Sigurdardottir
Birgitte Bjerkely
Trond G. Jenssen
Per Mathisen
Charlotte von der Lippe
Kristin Ørstavik
Ketil Heimdal
Dag Olav Dahle
Mina Susanne Weedon-Fekjær
Olga Solberg
Hege K. Pihlstrøm
机构
[1] Oslo University Hospital,Centre for Rare Disorders
[2] Oslo University Hospital,Department of Surgery, Inflammation Medicine and Transplantation, Section of Nephrology
[3] Rikshospitalet HF,Institute of Clinical Medicine, Faculty of Medicine
[4] University of Oslo,Department of Cardiology
[5] Oslo University Hospital,Department of Neurology, Section for Rare Neuromuscular Disorders
[6] Rikshospitalet HF,Department of Medical Genetics
[7] Oslo University Hospital,undefined
[8] Rikshospitalet HF,undefined
[9] Oslo University Hospital,undefined
[10] Rikshospitalet HF,undefined
关键词
Quality of life; HRQOL; SF-36; Longitudinal studies; Fabry disease; ERT; Kidney disease; Neuropathic pain;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The impact of demographic and clinical characteristics on the trajectories of health-related quality of life among patients with Fabry disease
    Sigurdardottir, Solrun
    Bjerkely, Birgitte
    Jenssen, Trond G.
    Mathisen, Per
    von der Lippe, Charlotte
    Orstavik, Kristin
    Heimdal, Ketil
    Dahle, Dag Olav
    Weedon-Fekjaer, Mina Susanne
    Solberg, Olga
    Pihlstrom, Hege K.
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [2] Health-related quality of life among patients with diabetes and foot ulcers: association with demographic and clinical characteristics
    Ribu, Lis
    Hanestad, Berit Rokne
    Moum, Torbjorn
    Birkeland, Kare
    Rustoen, Tone
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (04) : 227 - 236
  • [3] Assessing the impact of pain on health-related quality of life (HRQoL) in patients with Fabry disease
    Lyn, Nicole
    Wang, Jennifer
    Ba, Sarah
    Wing, Synne
    Pulikottil-Jacob, Ruth
    DasMahapatra, Pronabesh
    [J]. MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [4] Impact of treatment with agalsidase beta on health-related quality of life in patients with Fabry disease
    Badia, X.
    Perez, P.
    Layola, M.
    Checa, D.
    Tutor, A.
    Alvarez, A.
    Torra, R.
    Torras, J.
    de Arriba, G.
    Garcia-Monco, C.
    Puig, J. M.
    Torregrosa, V.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S31 - S31
  • [5] The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life
    Lenderking, WR
    Hillson, E
    Crawley, JA
    Moore, D
    Berzon, R
    Pashos, CL
    [J]. VALUE IN HEALTH, 2003, 6 (05) : 560 - 565
  • [6] Investigation of health-related quality of life in patients with Fabry disease in Japan
    Tsuboi, K.
    Nitta, M.
    Ueda, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S57 - S57
  • [7] BURDEN OF DISEASE IN PATIENTS WITH FABRY DISEASE: HEALTH-RELATED QUALITY OF LIFE AND ASSOCIATED FACTORS
    Santamaria, Rafael
    De Juan-Ribera, Joaquin
    Martinez-Sanchez, Felisa
    Pendon-Ruiz De Mier, Victoria
    Gil-Garcia, Carmen
    Jose Lopez-Ruiz, M.
    Casado, Araceli
    Ordovas, Manuel
    Espinosa, Mario
    Dolores Del Pino, M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [8] The role of demographic characteristics and comorbidities in hemodialysis patients' health-related quality of life
    Moisoglou, I
    Margariti, E.
    Kollia, K.
    Droulias, J.
    Savva, L.
    [J]. HIPPOKRATIA, 2017, 21 (04) : 163 - 168
  • [9] Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of life
    Tusek-Bunc, Ksenija
    Petek, Davorina
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [10] Comorbidities and characteristics of coronary heart disease patients: their impact on health-related quality of life
    Ksenija Tušek-Bunc
    Davorina Petek
    [J]. Health and Quality of Life Outcomes, 14